The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS
Open accessAbstract
Tumor immunity in patients with primary intracranial tumors was assessed in relation to the general status of host immunocompetence. Lymphocyte sensitization to tumor-specific membrane antigens was demonstrated by the proliferative response of lymphocytes in the presence of autochthonous tumor cells. Paradoxically, one-half of the patients could not be sensitized to a primary antigen, dinitrochlorobenzene; existing delayed hypersensitivity was also depressed, as measured by skin tests and lymphocyte transformation in response to common antigens. A heat-stable factor in patients' sera blocked cell-mediated tumor immunity. In addition, these "enhancing" sera consistently suppressed the blastogenic response of autologous and homologous lymphocytes to phytohemagglutinin and to membrane antigens on allogeneic cells in the one-way mixed lymphocyte culture. When patients' leukocytes were washed and autologous plasma replaced with normal plasma, reactivity in the mixed lymphocyte culture increased to normal values. In vitro immunosuppressive activity in patients' plasma or sera correlated with depressed delayed hypersensitivity. After removal of the tumor, suppressor activity disappeared. IgG fractions of patient sera contained strong immunosuppressive activity. These data suggest that the suppressor factor may be an isoantibody elicited by the tumor that also binds to receptors on the lymphocyte membrane. In addition to specifically blocking cell-mediated tumor immunity, enhancing sera may broadly depress host immunocompetence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOME RAPID APPROXIMATE STATISTICAL PROCEDURES
Wilcoxon, F. (1950) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1950.tb53974.x · Cited by 1,200
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Sjögren, H. O., Hellström, I., Bansal, S. C., & Hellström, K. E. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.6.1372 · Cited by 678
Impaired immunologic reactivity and recurrence following cancer surgery
Eilber, F. R., & Morton, D. L. (1970) · Cancer · doi:10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v · Cited by 665
One-Way Stimulation in Mixed Leukocyte Cultures
Bach, F. H., & Voynow, N. K. (1966) · Science · doi:10.1126/science.153.3735.545 · Cited by 528
Brain-associated Θ antigen: Reactivity of rabbit anti-mouse brain with mouse lymphoid cells
Golub, E. S. (1971) · Cellular Immunology · doi:10.1016/0008-8749(71)90070-0 · Cited by 427
Impaired delayed hypersensitivity in systemic lupus erythematosus
Horwitz, D. A. (1972) · Arthritis & Rheumatism · doi:10.1002/art.1780150406 · Cited by 135
Self-citationMixed lymphocyte culture and HL-A.
Eijsvoogel, V. P., Schellekens, P. T. A., Breur-Vriesendorp, B. S., Raat-Koning, L., Koch, C., van Leeuwen, A., & Jj, V. R. (1971) · PubMed · Cited by 58
Blaese, R. M., Oppenheim, J. J., Seeger, R. C., & Waldmann, T. A. (1972) · Cellular Immunology · doi:10.1016/0008-8749(72)90027-5 · Cited by 35
Cited by
Brain immunology and immunotherapy in brain tumours
Sampson, J. H., Gunn, M. D., Fecci, P. E., & Ashley, D. M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0224-7 · Cited by 722
Glioblastoma multiforme: a review of where we have been and where we are going
Adamson, C., Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Mattox, A. K., & Bigner, D. D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903052764 · Cited by 550
Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/noq142 · Cited by 433
de Martin, R., Haendler, B., Hofer-Warbinek, R., Gaugitsch, H., Wrann, M., Schlüsener, H., Seifert, J. M., Bodmer, S., Fontana, A., & Hofer, E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02700.x · Cited by 384
Wrann, M., Bodmer, S., de Martin, R., Siepl, C., Hofer-Warbinek, R., Frei, K., Hofer, E., & Fontana, A. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02411.x · Cited by 332
Microglia function in brain tumors
Watters, J. J., Schartner, J. M., & Badie, B. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20485 · Cited by 329
Immune defects observed in patients with primary malignant brain tumors
Dix, A. R., Brooks, W. H., Roszman, T. L., & Morford, L. A. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00203-9 · Cited by 323
Self-citationT-cell Dysfunction in Glioblastoma: Applying a New Framework
Woroniecka, K. I., Rhodin, K. E., Chongsathidkiet, P., Keith, K. A., & Fecci, P. E. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0047 · Cited by 315
Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
Mathios, D., Kim, J. E., Mangraviti, A., Phallen, J., Park, C.-K., Jackson, C. M., Garzon-Muvdi, T., Kim, E., Theodros, D., Polanczyk, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2942 · Cited by 296
Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dörries, R., Schlingensiepen, K.-H., & Brysch, W. (1993) · Journal of Neurosurgery · doi:10.3171/jns.1993.78.6.0944 · Cited by 146
Habashy, K. J., Mansour, R., Moussalem, C., Sawaya, R., & Massaad, M. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01864-w · Cited by 95
Metadata
- Authors
- Brooks, W. H., Netsky, M. G., Normansell, D. E., & Horwitz, D. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1972-12-01
- Volume
- 136
- Issue
- 6
- Pages
- 1631-1647
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2046542779
- Cited by
- 368
- References
- 9
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.